Skip to main content
. 2021 Mar 23;22:90. doi: 10.1186/s12931-021-01683-2

Fig. 1.

Fig. 1

Patient flow through the study (overall population). COPD chronic obstructive pulmonary disease, BDP beclometasone dipropionate, FF formoterol fumarate, G glycopyrronium, BUD budesonide, ITT intention-to-treat, PP per protocol